BT-061 is a humanized, therapeutic monoclonal antibody, which, based on the current state of knowledge, binds to and thus activates special cells of the immune system, the so-called regulatory T cells.
- Target indications: (rheumatoid arthritis, psoriasis)
- Possible upside indications: systemic lupus erythematosus, inflammatory gastro-intestinal diseases, multiple sclerosis, type 1 diabetes, allergie
